Novartis puts its India-listed entity for up for sale

The strategic review will include an assessment of the 70.68% shareholding of Novartis AG in Novartis India. Novartis said there is no assurance that the strategic review of Novartis India will be completed in 2024, or that the outcome would result in the implementation of any transaction.

from Stocks-Markets-Economic Times https://ift.tt/ZNRJ1Fd